222 related articles for article (PubMed ID: 16842086)
1. Coumarins as inhibitors of HIV reverse transcriptase.
Kostova I
Curr HIV Res; 2006 Jul; 4(3):347-63. PubMed ID: 16842086
[TBL] [Abstract][Full Text] [Related]
2. Structure-Activity Relationships of Synthetic Coumarins as HIV-1 Inhibitors.
Kostova I; Raleva S; Genova P; Argirova R
Bioinorg Chem Appl; 2006; 2006():68274. PubMed ID: 17497014
[TBL] [Abstract][Full Text] [Related]
3. In vitro anti-human immunodeficiency virus (HIV) activity of the chromanone derivative, 12-oxocalanolide A, a novel NNRTI.
Xu ZQ; Buckheit RW; Stup TL; Flavin MT; Khilevich A; Rizzo JD; Lin L; Zembower DE
Bioorg Med Chem Lett; 1998 Aug; 8(16):2179-84. PubMed ID: 9873509
[TBL] [Abstract][Full Text] [Related]
4. [Progress in the new nonnucleoside anti-HIV reverse transcriptase inhibitor-DCK].
Guo HF; Xie L
Yao Xue Xue Bao; 2008 Oct; 43(10):997-1002. PubMed ID: 19127862
[TBL] [Abstract][Full Text] [Related]
5. Plant Coumarins with Anti-HIV Activity: Isolation and Mechanisms of Action.
Sharapov AD; Fatykhov RF; Khalymbadzha IA; Zyryanov GV; Chupakhin ON; Tsurkan MV
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769163
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of a group of nonnucleoside reverse transcriptase inhibitors with structural diversity and potent anti-human immunodeficiency virus activity.
Yang SS; Fliakas-Boltz V; Bader JP; Buckheit RW
Leukemia; 1995 Oct; 9 Suppl 1():S75-85. PubMed ID: 7475321
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of action and resistant profile of anti-HIV-1 coumarin derivatives.
Huang L; Yuan X; Yu D; Lee KH; Chen CH
Virology; 2005 Feb; 332(2):623-8. PubMed ID: 15680427
[TBL] [Abstract][Full Text] [Related]
8. Coumarins as Potential Inhibitors of DNA Polymerases and Reverse Transcriptases. Searching New Antiretroviral and Antitumoral Drugs.
Garro HA; Pungitore CR
Curr Drug Discov Technol; 2015; 12(2):66-79. PubMed ID: 26179474
[TBL] [Abstract][Full Text] [Related]
9. Coumarin-based derivatives with potential anti-HIV activity.
Xu Z; Chen Q; Zhang Y; Liang C
Fitoterapia; 2021 Apr; 150():104863. PubMed ID: 33582266
[TBL] [Abstract][Full Text] [Related]
10. Antiviral activity and mechanism of action of calanolide A against the human immunodeficiency virus type-1.
Currens MJ; Gulakowski RJ; Mariner JM; Moran RA; Buckheit RW; Gustafson KR; McMahon JB; Boyd MR
J Pharmacol Exp Ther; 1996 Nov; 279(2):645-51. PubMed ID: 8930167
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of human immunodeficiency virus type 1 reverse transcriptase activity by cordatolides isolated from Calophyllum cordato-oblongum.
Dharmaratne HR; Wanigasekera WM; Mata-Greenwood E; Pezzuto JM
Planta Med; 1998 Jun; 64(5):460-1. PubMed ID: 9690350
[TBL] [Abstract][Full Text] [Related]
12. Kinetic analysis of inhibition of human immunodeficiency virus type-1 reverse transcriptase by calanolide A.
Currens MJ; Mariner JM; McMahon JB; Boyd MR
J Pharmacol Exp Ther; 1996 Nov; 279(2):652-61. PubMed ID: 8930168
[TBL] [Abstract][Full Text] [Related]
13. Progress of bis(heteroaryl)piperazines (BHAPs) as non-nucleoside reverse transcriptase inhibitors (NNRTIs) against human immunodeficiency virus type 1 (HIV-1).
Xu H
Mini Rev Med Chem; 2010 Jan; 10(1):62-72. PubMed ID: 20380641
[TBL] [Abstract][Full Text] [Related]
14. Advances in rationally designed dual inhibitors of HIV-1 reverse transcriptase and integrase.
Gu SX; Xue P; Ju XL; Zhu YY
Bioorg Med Chem; 2016 Nov; 24(21):5007-5016. PubMed ID: 27658796
[TBL] [Abstract][Full Text] [Related]
15. Anti-HIV-1 activity of calanolides used in combination with other mechanistically diverse inhibitors of HIV-1 replication.
Buckheit RW; Russell JD; Xu ZQ; Flavin M
Antivir Chem Chemother; 2000 Sep; 11(5):321-7. PubMed ID: 11142630
[TBL] [Abstract][Full Text] [Related]
16. Analysis of nonnucleoside drug-resistant variants of human immunodeficiency virus type 1 reverse transcriptase.
Boyer PL; Currens MJ; McMahon JB; Boyd MR; Hughes SH
J Virol; 1993 Apr; 67(4):2412-20. PubMed ID: 7680393
[TBL] [Abstract][Full Text] [Related]
17. Designing anti-AIDS drugs targeting the major mechanism of HIV-1 RT resistance to nucleoside analog drugs.
Sarafianos SG; Hughes SH; Arnold E
Int J Biochem Cell Biol; 2004 Sep; 36(9):1706-15. PubMed ID: 15183339
[TBL] [Abstract][Full Text] [Related]
18. [Progress in HIV non-nucleoside reverse transcriptase inhibitors (NNRTIs)].
Zhou T; Xie L
Yao Xue Xue Bao; 2004 Aug; 39(8):666-72. PubMed ID: 15563074
[No Abstract] [Full Text] [Related]
19. The development of anti-HIV-1 drugs.
Lu XF; Chen ZW
Yao Xue Xue Bao; 2010 Feb; 45(2):165-76. PubMed ID: 21348415
[TBL] [Abstract][Full Text] [Related]
20. Human immunodeficiency virus mutagenesis during antiviral therapy: impact of drug-resistant reverse transcriptase and nucleoside and nonnucleoside reverse transcriptase inhibitors on human immunodeficiency virus type 1 mutation frequencies.
Chen R; Yokoyama M; Sato H; Reilly C; Mansky LM
J Virol; 2005 Sep; 79(18):12045-57. PubMed ID: 16140780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]